A detailed history of Bank Of America Corp transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of America Corp holds 709,652 shares of ENTA stock, worth $6.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
709,652
Previous 595,913 19.09%
Holding current value
$6.63 Million
Previous $7.73 Million 4.77%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.05 - $16.54 $1.14 Million - $1.88 Million
113,739 Added 19.09%
709,652 $7.36 Million
Q2 2024

Aug 14, 2024

BUY
$11.43 - $17.02 $909,222 - $1.35 Million
79,547 Added 15.41%
595,913 $7.73 Million
Q1 2024

May 15, 2024

BUY
$10.08 - $17.46 $5.08 Million - $8.8 Million
504,106 Added 4111.79%
516,366 $9.02 Million
Q4 2023

Feb 14, 2024

SELL
$8.18 - $10.78 $355,519 - $468,520
-43,462 Reduced 78.0%
12,260 $115,000
Q2 2023

Aug 14, 2023

SELL
$20.68 - $39.85 $3.45 Million - $6.65 Million
-166,986 Reduced 74.98%
55,722 $1.19 Million
Q1 2023

May 12, 2023

BUY
$38.82 - $54.59 $6.5 Million - $9.14 Million
167,431 Added 302.89%
222,708 $9.01 Million
Q4 2022

Feb 10, 2023

BUY
$40.77 - $53.73 $463,554 - $610,910
11,370 Added 25.9%
55,277 $2.57 Million
Q3 2022

Nov 14, 2022

BUY
$48.29 - $71.27 $1.51 Million - $2.23 Million
31,273 Added 247.53%
43,907 $2.28 Million
Q2 2022

Aug 12, 2022

SELL
$38.13 - $76.93 $957,596 - $1.93 Million
-25,114 Reduced 66.53%
12,634 $597,000
Q1 2022

May 16, 2022

BUY
$56.06 - $74.11 $1.07 Million - $1.42 Million
19,154 Added 103.01%
37,748 $2.69 Million
Q4 2021

Feb 08, 2022

BUY
$60.19 - $97.37 $618,331 - $1 Million
10,273 Added 123.46%
18,594 $1.39 Million
Q3 2021

Nov 15, 2021

BUY
$41.02 - $58.65 $45,286 - $64,749
1,104 Added 15.3%
8,321 $472,000
Q2 2021

Sep 13, 2021

BUY
$43.76 - $53.11 $315,815 - $383,294
7,217 New
7,217 $317,000

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.